SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-010986
Filing Date
2022-05-05
Accepted
2022-05-05 08:30:31
Documents
20
Period of Report
2022-05-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20220429_8k.htm   iXBRL 8-K 27830
2 EXHIBIT 99.1 ex_367683.htm EX-99.1 15641
7 c01.jpg GRAPHIC 211820
8 c02.jpg GRAPHIC 253685
9 c03.jpg GRAPHIC 253596
10 c04.jpg GRAPHIC 284172
11 c05.jpg GRAPHIC 216590
12 c06.jpg GRAPHIC 229956
  Complete submission text file 0001437749-22-010986.txt   2180779

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20220505.xsd EX-101.SCH 3600
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20220505_def.xml EX-101.DEF 11915
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20220505_lab.xml EX-101.LAB 15955
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20220505_pre.xml EX-101.PRE 12126
14 EXTRACTED XBRL INSTANCE DOCUMENT gnpx20220429_8k_htm.xml XML 2639
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

IRS No.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 22894240
SIC: 2834 Pharmaceutical Preparations